Skip to main content

ORIGINAL RESEARCH article

Front. Surg., 16 June 2022
Sec. Surgical Oncology

RETRACTED: Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients

Retracted
\r\nHua YangHua YangYongjun Liu
\r\nYongjun Liu*
  • Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Citation: Yang H and Liu Y (2022) Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients. Front. Surg. 9:889294. doi: 10.3389/fsurg.2022.889294

Received: 4 March 2022; Accepted: 11 April 2022;
Published: 16 June 2022;
Retracted: 11 October 2023.

Edited by:

Sebastian Lee, Department of Medical Oncology, The Royal Melbourne Hospital, Australia

Reviewed by:

Ruoyu Deng, Fudan University, China
Einar Kristiansen, Norwegian Radium Hospital, Oslo University Hospital, Norway
Samuel Smith, Prince of Wales Hospital, University of New South Wales, Australia
Xiaorong Bai, Gansu Provincial Cancer Hospital, China

Specialty section: This article was submitted to Surgical Oncology, a section of the journal Frontiers in Surgery.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.